CBD occlusal appliance
Occlusal appliance manufactured with CBD molecules released from material to patients oral cavity during sleep time
CBD OCC APPLoading study record…
Loading study record…
Evaluation of the efficacy of the occlusal appliance with active cannabidiol (CBD) molecules in TMD patients
Locally preserved from ClinicalTrials.govOpen ClinicalTrials.govlast source update 2021-03-01
What this record can show
This locally preserved record separates the registered protocol from source-reported registry results. Neither is a treatment recommendation.
Registry facts
Occlusal appliance therapies are used in TMD patients. In this research the active CBD molecules will be released from the occlusal appliance during nighttime, in population of patients suffering from TMD. The effectiveness of the myorelaxation (sEMG of mastcatory muscles activity) and analgesic effect( VAS analysis) of occlusal appliance with the CBD molecules will be compared to the traditional acrylic-resin material used so far for occlusal appliance manufacture. The aim of the research is the evaluation of the innovative material effectiveness, used for the production of the occlusal appliance.
Linked local records
Local links use governed condition terms or exact source-reported intervention names. They are navigation candidates, not efficacy claims.
Research network
Interventions
Occlusal appliance manufactured with CBD molecules released from material to patients oral cavity during sleep time
CBD OCC APPAcrylic resin occlusal appliance during sleep time
ACRYLIC OCC APPEligibility
primary outcomes
Time frame: 40 days
Reduction of sEMG activity of masseter muscle
secondary outcomes
Time frame: 40 days
Reduction of pain intensity in VAS
Publications